Hutchmed (China)
HCM
Enerpac Tool
EPAC
Precision Drilling
PDS
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 12.660
- -0.370-2.84%
Close Apr 1 16:00 ET
- 12.660
- 0.0000.00%
Post 16:20 ET
690.27MMarket Cap-10.14P/E (TTM)
12.970High12.220Low529.87KVolume12.650Open13.030Pre Close6.69MTurnover1.88%Turnover RatioLossP/E (Static)54.52MShares28.09052wk High1.40P/B357.83MFloat Cap11.10052wk Low--Dividend TTM28.26MShs Float28.090Historical High--Div YieldTTM5.76%Amplitude11.100Historical Low12.620Avg Price1Lot Size
Bicara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 106.55%82.39M | 94.62%26.64M | 116.45%20.63M | 5.93%39.89M | 13.69M | 9.53M | 37.66M |
| Selling and administrative expenses | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| -General and administrative expense | 102.44%18.77M | 116.13%6.75M | 83.87%4.76M | 46.15%9.27M | --3.13M | --2.59M | --6.34M |
| Research and development costs | 107.79%63.62M | 88.25%19.88M | 128.62%15.86M | -2.22%30.62M | --10.56M | --6.94M | --31.31M |
| Operating profit | -106.55%-82.39M | -94.62%-26.64M | -116.45%-20.63M | -5.93%-39.89M | -13.69M | -9.53M | -37.66M |
| Net non-operating interest income expense | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 1,316.67%1.31M | 1.3M | 13K | -108K |
| Non-operating interest income | 1,009.67%14.58M | 350.88%5.87M | 24,107.69%3.15M | 32,750.00%1.31M | --1.3M | --13K | --4K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | --112K |
| Other net income (expense) | -16,656.25%-13.41M | -49K | -13.33M | -80K | |||
| Other non- operating income (expenses) | ---- | ---- | ---- | -16,656.25%-13.41M | ---49K | ---13.33M | ---80K |
| Income before tax | -30.45%-67.81M | -67.04%-20.77M | 23.48%-17.48M | -37.35%-51.98M | -12.44M | -22.85M | -37.84M |
| Income tax | 3,640.00%187K | 3,620.00%186K | 0 | 400.00%5K | 5K | 0 | 1K |
| Net income | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Net income continuous Operations | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | ---12.44M | ---22.85M | ---37.85M |
| Minority interest income | |||||||
| Net income attributable to the parent company | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | |||||||
| Net income attributable to common stockholders | -30.80%-68M | -68.46%-20.96M | 23.48%-17.48M | -37.36%-51.99M | -12.44M | -22.85M | -37.85M |
| Basic earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Diluted earnings per share | -164.77%-4.05 | -6.54%-0.39 | -138.02%-1.6 | 37.59%-1.5296 | -0.366 | -0.6722 | -2.451 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025